ST Tianbang announced the 2024 annual performance forecast, expecting net income attributable to shareholders of the listed company to be 1.36 billion to -1.56 billion yuan, turning losses into profits year-on-year. The significant growth in company performance is primarily due to the investment income of 0.995 billion yuan generated by the sale of a 32.91% stake in the associated company Shiji Biology in the first quarter, as well as the recovery of hog prices and the effectiveness of cost reduction measures, leading to a decrease in hog sale costs, with the main business of hog farming achieving profitability for three consecutive quarters.